# Effects of probiotic supplementation on immune and inflammatory markers in athletes: an umbrella review and re-analysis of published meta-analyses of randomised controlled trials

**Authors:** Lei Chen, Aichun Li, Wenhao Chen, Junlai Zhou, Yujia Kou

PMC · DOI: 10.7717/peerj.20809 · PeerJ · 2026-02-26

## TL;DR

Probiotics may help reduce inflammation and boost immunity in athletes, based on a review of multiple studies.

## Contribution

This umbrella review provides a comprehensive synthesis and re-analysis of probiotic effects on immune markers in athletes.

## Key findings

- Probiotic supplementation significantly reduced pro-inflammatory TNF-α levels in athletes.
- Probiotics increased secretory IgA and IFN-γ, indicating improved mucosal immunity and immune response.
- No significant effects were found for IL-6, IL-8, and IL-10.

## Abstract

Intensive training and competition can compromise athletes’ immune function and elevate inflammatory responses. Although probiotics are widely studied as a nutritional intervention, existing meta-analyses have reported inconsistent findings regarding their efficacy. This umbrella review and re-analysis aimed to synthesize and evaluate the available evidence on the effects of probiotic supplementation on specific immune and inflammatory markers in athletes.

We systematically searched PubMed, Cochrane Library, Web of Science, EMbase, and Scopus for meta-analyses published up to December 1, 2025, and supplemented these with recent randomised controlled trials (RCTs) (up to December 15, 2025). Quality was assessed using Assessment of Multiple Systematic Reviews 2 (AMSTAR2) and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tools. Outcomes of interest included tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), immunoglobulin A (IgA) and interferon-gamma (IFN-γ). Overlap among studies was evaluated using the Graphical Representation of Overlap for OVErviews (GROOVE) tool, and data were re-analyzed using random- or fixed-effects models in Stata 15.0.

This umbrella analysis incorporated five meta-analyses (encompassing 69 RCTs) and one additional recent RCT, totaling 3,413 participants. Results showed that probiotic supplementation significantly reduced levels of the pro-inflammatory marker TNF-α (Effect Size (ES) = −0.59, 95% Confidence Interval (CI) [−0.94 to −0.24], P = 0.001). Probiotic supplementation significantly increased secretory IgA (ES = 0.30, 95% CI [0.03–0.57], P = 0.031) and IFN-γ levels (P < 0.01). In contrast, no significant effects were observed for IL-6 (ES = −0.09, 95% CI [−0.26 to 0.08]; P = 0.283), IL-8 (ES = −0.38, 95% CI [0.87 to 0.11], P = 0.132) and the anti-inflammatory cytokine IL-10 (ES = 0.15, 95% CI [−0.21 to 0.52], P = 0.411).

These robust results demonstrate that probiotic supplementation modulates exercise-induced immune disturbances in athletes by attenuating pro-inflammatory responses and enhancing mucosal immunity. These findings support its role as a strategic nutritional approach for immune protection. Future research should emphasize strain-specific efficacy and optimal dosing to enable personalized recommendations for athletes.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IL6 (interleukin 6), CXCL8 (C-X-C motif chemokine ligand 8), IL10 (interleukin 10), CD79A (CD79a molecule), IFNG (interferon gamma)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** URTIs (MESH:D012141), inflammation (MESH:D007249), muscle damage (MESH:D009133), immune disturbances (MESH:D007154), infections (MESH:D007239)
- **Chemicals:** dietary fiber (MESH:D004043)
- **Species:** Bifidobacterium longum subsp. infantis (subspecies) [taxon 1682], Bifidobacterium longum (species) [taxon 216816], Lacticaseibacillus casei (species) [taxon 1582], Fructilactobacillus fructivorans (species) [taxon 1614], Ligilactobacillus salivarius (species) [taxon 1624], Homo sapiens (human, species) [taxon 9606], Lacticaseibacillus rhamnosus (species) [taxon 47715], Pediococcus acidilactici (species) [taxon 1254], Levilactobacillus brevis (species) [taxon 1580], Bifidobacterium bifidum (species) [taxon 1681], Limosilactobacillus fermentum (species) [taxon 1613], Lacticaseibacillus paracasei (species) [taxon 1597], Lactococcus lactis (species) [taxon 1358], Athletes (genus) [taxon 1337349], Lactobacillus helveticus (species) [taxon 1587], Lactiplantibacillus plantarum (species) [taxon 1590], Lactobacillus acidophilus (species) [taxon 1579], Bifidobacterium animalis subsp. lactis (subspecies) [taxon 302911], Bifidobacterium breve (species) [taxon 1685]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950187/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950187/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950187/full.md

---
Source: https://tomesphere.com/paper/PMC12950187